As discussions surrounding longevity and “bio-hacking” become increasingly prevalent, a medication initially intended for specific medical applications is now being considered for a vastly different purpose. Rapamycin, first identified in the 1970s and subsequently approved for use in transplant medicine, is being suggested by some as a possible means to mitigate the effects of aging.<\/p>\n
Dr. Vassily Eliopoulos, a specialist in longevity, recently contributed to the dialogue, labeling rapamycin as one of the most contentious substances in this field. He stated, \u201cRapamycin has been shown to prolong lifespan in every animal species it has been tested on. Longevity-focused physicians are prescribing it off-label to healthy individuals. The medical community is divided on this issue. Meanwhile, biohackers are conducting self-experiments based on studies they find online.\u201d He elaborated on the drug’s background and transformation, stating, \u201cInitially created as an antifungal agent, rapamycin later became a widely used immunosuppressant in organ transplantation, where it has been approved by the FDA for decades.\u201d<\/p>\n
DISCLAIMER:<\/strong> This article is derived from publicly available information and insights from the experts consulted. Always seek the advice of your healthcare provider before initiating any new health regimen.<\/p>\n The proposed anti-aging properties of rapamycin are linked to its influence on a crucial cellular mechanism. Dr. Eliopoulos explained, \u201cmTOR acts as a regulatory switch for cell growth. When activated, cells grow, divide, and develop. Conversely, when it is inhibited, cells engage in maintenance activities, removing damaged proteins and recycling cellular waste, thus contributing to the prevention of aging.\u201d He noted that blocking this pathway might stimulate the body\u2019s inherent \u201cclean-up\u201d processes. While the scientific evidence, particularly from animal studies, is persuasive, research involving humans is still in the early stages.<\/p>\n \u201cResearch on animals indicates that diminished mTOR signaling can extend lifespans by up to 20% in yeast, 19% in worms, 24% in flies, and as much as 60% in mice,\u201d Dr. Eliopoulos remarked. \u201cNotably, in mice, rapamycin was effective in extending lifespan even when treatment began in middle age.\u201d However, he pointed out the limitations of the existing human data: \u201cOne cohort study indicated that users might have experienced a reduction in biological age by nearly four years, although this was based on group averages rather than individual results.\u201d He emphasized, \u201cThe animal studies are indeed compelling, but human data remains preliminary. Both statements are accurate, and anyone suggesting otherwise is oversimplifying the issue.\u201d<\/p>\n Dr. Palleti Siva Karthik Reddy, a consultant physician at Elite Care Clinic, shared with indianexpress.com that \u201cWhile current evidence on rapamycin is encouraging, it is still incomplete regarding its effects on human longevity. Most robust data comes from animal studies, which have demonstrated the drug’s potential to extend lifespan by modulating aging-related pathways, particularly the mTOR pathway.\u201d<\/p>\n Nonetheless, he cautioned that applying these findings to humans is complex. \u201cExisting human studies are limited, typically short-term, and often focus on specific health conditions rather than on aging as a whole. At this point, it should be considered more of an experimental treatment than a validated anti-aging solution.\u201d<\/p>\n Utilizing rapamycin without medical supervision poses significant risks, as it is an immunosuppressive medication originally intended for transplant patients. \u201cFor otherwise healthy individuals, unsupervised usage can heighten the risk of infections, impair the healing process, and potentially disrupt glucose and lipid metabolism. Furthermore, there is a lack of clarity regarding the appropriate dosage, timing, and long-term safety for healthy populations. Self-prescribing such substances based on emerging trends may lead to unintended consequences rather than tangible benefits,\u201d Dr. Reddy warned.<\/p>\n DISCLAIMER:<\/strong> This article is based on information from the public domain and\/or the experts we consulted. Always consult your healthcare provider before starting any new health regimen.<\/p>\n","protected":false},"excerpt":{"rendered":" As discussions surrounding longevity and “bio-hacking” become increasingly prevalent, a medication initially intended for specific medical applications is now being considered for a vastly different purpose. Rapamycin, first identified in the 1970s and subsequently approved for use in transplant medicine, is being suggested by some as a possible means to mitigate the effects of aging. […]<\/p>\n","protected":false},"author":2,"featured_media":8917,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[833,40,371],"tags":[],"class_list":["post-8918","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-in-health","category-india","category-in-lifestyle"],"yoast_head":"\n